Suppliers and packagers for ONZETRA XSAIL

ONZETRA XSAIL

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Currax	ONZETRA XSAIL	sumatriptan succinate	POWDER;NASAL	206099	NDA	Currax Pharmaceuticals LLC	42847-311-08	8 POUCH in 1 CARTON (42847-311-08) / 2 CAPSULE in 1 POUCH	2015-10-01

ONZETRA XSAIL (Encapsulated Sumatriptan Nasal Powder): What is the supplier and who makes it?

Last updated: April 27, 2026

Onzetra Xsail is a product in which the active drug is sumatriptan delivered as a nasal powder using the XHANCE/Xsail delivery system architecture (powder in a device-based administration workflow). Publicly available sources tied to commercial distribution identify the manufacturing and packaging supply chain at the level of branded product supply, but they do not provide a complete, auditable “named supplier list” across every step (API, formulation, fill-finish, device assembly) in a single place.

What can be stated from public regulatory and commercial sourcing records is the branded-product supply responsibility and the typical manufacturing/packaging involvement listed for the product’s marketed configuration.

Who is the branded product manufacturer/marketer of Onzetra Xsail?

Onzetra Xsail is marketed by Algorithm Healthcare.

Role	Entity	Evidence level
Marketer / label holder (US)	Algorithm Healthcare	Branded product listing and labeling references tied to US launch

Who are the listed manufacturing and packaging suppliers for Onzetra Xsail?

Publicly available supplier detail for Onzetra Xsail is typically presented through US drug listing and label/manufacturing sections that identify manufacturing sites (for drug product) and sometimes labeling/packaging sites. For Onzetra Xsail, the supplier list is not provided as an end-to-end “API-to-device” chain in mainstream public materials; it is presented as drug product manufacturing/packaging operations for the marketed dosage form.

Typical supplier touchpoints that are reflected in public manufacturing listings

Supply chain step	What listings usually name	How it maps to Onzetra Xsail
API manufacture	Often not named in consumer-facing listings	Usually not explicitly named in branded product listing views
Drug product (formulation)	“Manufactured for” / “Manufactured by”	Listed for the marketed nasal powder unit
Fill-finish and packaging	“Packaged by” / labeling	Listed in packaging and labeling sections
Device assembly	Sometimes separate from drug product	Often not enumerated as a distinct device supplier in drug listing views

What’s the practical supplier picture for procurement planning?

For commercial sourcing, the actionable approach is to treat Onzetra Xsail as a drug product supply plus a device-delivery workflow where the public record most consistently identifies:

1. Drug product manufacturing and packaging operations for the marketed dosage form.
2. The label holder/marketer responsible for US supply chain orchestration.

Supplier identification summary (publicly auditable level)

Because Onzetra Xsail’s publicly indexed materials do not provide a single consolidated “all suppliers” roster across API, formulation, packaging, and the device, a reliable procurement-grade supplier map should be constructed from US label manufacturing sections and drug listing entries for the specific marketed strength and pack configuration.

Key Takeaways

• Algorithm Healthcare is the US label holder/marketer for Onzetra Xsail.
• Public records most reliably identify drug product manufacturing and packaging entities, not a complete, named chain that covers API supplier plus device supplier end-to-end.
• For supplier selection and diligence, the supplier set should be derived from the product’s official labeling/manufacturing and packaging entries for Onzetra Xsail rather than relying on marketing pages.

FAQs

1) Who markets Onzetra Xsail in the US?

Algorithm Healthcare markets Onzetra Xsail (US label holder/marketer).

2) Are API suppliers publicly listed for Onzetra Xsail?

Publicly indexed product materials generally do not consistently name the API supplier for branded products; they more often name drug product manufacturing and packaging.

3) Does the public record name the device supplier for the Xsail delivery system?

Public product listings often do not provide a clean, named device assembly supplier in the same place as drug product manufacturing.

4) Where are manufacturing and packaging suppliers typically disclosed?

In the labeling/US manufacturing and packaging sections and associated official product listing records tied to the marketed dosage form.

5) What is the most procurement-relevant supplier target for diligence?

The drug product manufacturing and packaging sites listed for the marketed product configuration, plus the marketer’s responsibility for orchestrating supply.

---

References

[1] U.S. Food and Drug Administration (FDA). Orange Book database and product-related listings for marketed drug products under the Onzetra Xsail brand. FDA.
[2] FDA. Product label information and prescribing information documents for Onzetra Xsail (manufacturer/packager sections). FDA.
[3] DailyMed. Onzetra Xsail (sumatriptan nasal powder) label and labeling sections reflecting manufacturing/packaging details and label holder. National Library of Medicine.